Evaluation of Head and Neck Cancer Patients: A National Survey
- 1 July 1988
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 114 (7) , 775-778
- https://doi.org/10.1001/archotol.1988.01860190079028
Abstract
• A review of the recent literature of otolaryngology–head and neck surgery reveals minimal guidance as to the use of laboratory and radiographic studies in the initial evaluation and subsequent follow-up of patients with head and neck cancer. A national survey was prepared and was sent to 105 otolaryngology–head and neck surgery teaching departments with 53 institutions responding. This survey shows that a baseline of laboratory and radiographic studies are routinely ordered. Follow-up is monthly the first year and every other month the second year. Specialized laboratory tests and radiographic studies are ordered on a caseby-case basis and based on cost effectiveness, research orientation, available resources, and, most importantly, the patient's needs. (Arch Otolaryngol Head Neck Surg 1988;114:775-778)This publication has 8 references indexed in Scilit:
- Serum ferritin as a tumor marker in patients with squamous cell carcinoma of the head and neckCancer, 1986
- Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapyCancer, 1985
- Metastatic Neck Disease: Evaluation by Computed TomographyJAMA Otolaryngology–Head & Neck Surgery, 1984
- The clinical significance of radiographically detected pulmonary neoplastic lesions in patients with head and neck cancer.Journal of Clinical Oncology, 1984
- The upper aerodigestive tract and neck: CT evaluation of recurrent tumors.Radiology, 1983
- Detection of metastatic liver disease. Use of liver scans and biochemical liver testsJAMA, 1982
- CEA levels in head and neck cancerCancer, 1976